Literature DB >> 31581803

Tailored oral anticoagulant prescription in patients with atrial fibrillation: Use and misuse of clinical risk prediction scores.

Marco Proietti1,2,3, Marco Vitolo4, Giuseppe Boriani4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31581803     DOI： 10.1177/2047487319877469

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN： 2047-4873            Impact factor:   7.804


× No keyword cloud information.
  3 in total

Review 1.  Anticoagulation in special patient populations with atrial fibrillation.

Authors:  Laura Ueberham; Gerhard Hindricks
Journal:  Herz       Date:  2021-07-05       Impact factor: 1.443

2.  Utility of risk prediction models to detect atrial fibrillation in screened participants.

Authors:  Michiel H F Poorthuis; Nicholas R Jones; Paul Sherliker; Rachel Clack; Gert J de Borst; Robert Clarke; Sarah Lewington; Alison Halliday; Richard Bulbulia
Journal:  Eur J Prev Cardiol       Date:  2021-05-22       Impact factor: 8.526

3.  Effect of SAcubitril/Valsartan on left vEntricular ejection fraction and on the potential indication for Implantable Cardioverter Defibrillator in primary prevention: the SAVE-ICD study.

Authors:  Federico Guerra; Ernesto Ammendola; Matteo Ziacchi; Vittorio Aspromonte; Pier Luigi Pellegrino; Giuseppe Del Giorno; Gabriele Dell'Era; Lorenzo Pimpini; Francesco Santoro; Roberto Floris; Giulia Stronati; Gerardo Nigro; Pasquale Paolisso; Alessandro Guido; Giampiero Maglia; Natale Daniele Brunetti; Angelo Carbone; Miriam Gravellone; Roberto Antonicelli; Michele Cannone; Michele Accogli; Antonio Dello Russo; Pietro Palmisano
Journal:  Eur J Clin Pharmacol       Date:  2021-07-19       Impact factor: 2.953
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.